tiprankstipranks
Morning Movers: Keros Therapeutics plummets after halting TROPOS trial dosing
The Fly

Morning Movers: Keros Therapeutics plummets after halting TROPOS trial dosing

Check out this morning’s top movers from around Wall Street, compiled by The Fly. 

Invest with Confidence:


HIGHER –

  • Intervac (IVAC) up 18% after announcing intention to commence quarterly dividend and pursuit of strategic alternatives
  • Gambling.com (GAMB) up 13% after announcing it entered into a definitive agreement to acquire Odds Holdings
  • Centene (CNC) up 2% after providing FY25 outlook and reaffirming its FY24 guidance


UP AFTER EARNINGS –


DOWN AFTER EARNINGS –


LOWER –

  • Keros Therapeutics (KROS) down 73% after halting dosing in the 3.0 mg/kg and 4.5 mg/kg treatment arms in the ongoing TROPOS trial

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App